对比增强乳腺X线与MRI鉴别微浸润癌与原位导管癌的临床及影像特征
研究纳入47例女性DCIS患者,比较DCISM与纯DCIS在CEM和MRI上的临床及影像特征,发现CEM的CSAmax、%RSCC、%RSMLO及增强形态分布和内强化模式在两组间有显著差异,CSAmax和%RSCC为DCISM独立预测因子,CEM的Logit(P)模型AUC为0.842。
要点
- CEM上DCISM的CSAmax、%RSCC和%RSMLO均显著高于纯DCIS。
- CEM的CSAmax、%RSCC及Logit(P)模型AUC分别为0.764、0.795、0.842,与MRI的CSAmax(AUC 0.739)无显著差异。
- DCISM与高级别核、粉刺型、腋窝淋巴结转移及高Ki-67阳性显著相关。
核心结论
- 肿瘤大小(CSAmax)、强化指数(%RS)和内强化模式(IEP)对DCISM有较高提示价值,DCISM倾向表达更具侵袭性的病理特征如高级别核、粉刺型坏死、腋窝淋巴结转移和Ki-67过表达,CEM与MRI一样有助于预测DCIS是否伴发DCISM。
研究设计与样本
- 回顾性纳入2019年5月至2023年8月诊断为DCIS的47例女性患者,按病理分为DCIS组和DCISM组,分析临床及影像特征,用多变量逻辑回归建立Logit(P)模型,用ROC分析和DeLong检验评估独立预测因子。
关键影像表现/征象
- CEM上DCISM的最大横截面积(CSAmax)显著高于DCIS(p=0.001)。
- CEM上头尾位和内外斜位强化病灶与背景的信号差百分比(%RSCC和%RSMLO)在DCISM中显著高于DCIS(p<0.001;p=0.008)。
- CEM上强化形态分布(EMD)和内强化模式(IEP)在DCIS与DCISM间有统计学差异(p=0.047;p=0.008)。
- MRI上仅CSAmax(p=0.012)和IEP(p=0.020)在两组间有显著统计学差异。
诊断标准与关键数值
- 多变量回归分析提示CEM或MR的CSAmax和CEM的%RSCC为DCISM独立预测因子(均p<0.05)。
- CSAmax(CEM)、%RSCC(CEM)、Logit(P)(CEM)和CSAmax(MR)的AUC分别为0.764、0.795、0.842和0.739。
- DeLong检验显示上述AUC值间无显著差异(均p>0.10)。
- DCISM与高级别核、粉刺型、高腋窝淋巴结转移及高Ki-67阳性显著相关(均p<0.05)。
临床应用与阅片要点
- CEM上CSAmax较大、%RSCC和%RSMLO较高、EMD和IEP特定模式提示DCISM可能。
- CEM的CSAmax和%RSCC可作为预测DCISM的独立指标,其诊断效能与MRI的CSAmax无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The prognosis of ductal carcinoma in situ with microinvasion (DCISM) is more similar to that of small invasive ductal carcinoma (IDC) than to pure ductal carcinoma in situ (DCIS). It is particularly important to accurately distinguish between DCISM and DCIS. The present study aims to compare the clinical and imaging characteristics of contrast-enhanced mammography (CEM) and magnetic resonance imaging (MRI) between DCISM and pure DCIS, and to identify predictive factors of microinvasive carcinoma, which may contribute to a comprehensive understanding of DCISM in clinical diagnosis and support surveillance strategies, such as surgery, radiation, and other treatment decisions.
MATERIALS AND METHODS: Forty-seven female patients diagnosed with DCIS were included in the study from May 2019 to August 2023. Patients were further divided into two groups based on pathological diagnosis: DCIS and DCISM. Clinical and imaging characteristics of these two groups were analyzed statistically. The independent clinical risk factors were selected using multivariate logistic regression and used to establish the logistic model [Logit(P)]. The diagnostic performance of independent predictors was assessed and compared using receiver operating characteristic (ROC) analysis and DeLong's test.
RESULTS: In CEM, the maximum cross-sectional area (CSAmax), the percentage signal difference between the enhancing lesion and background in the craniocaudal and mediolateral oblique projection (%RSCC, and %RSMLO) were found to be significantly higher for DCISM compared to DCIS (p = 0.001; p < 0.001; p = 0.008). Additionally, there were noticeable statistical differences in the patterns of enhancement morphological distribution (EMD) and internal enhancement pattern (IEP) between DCIS and DCISM (p = 0.047; p = 0.008). In MRI, only CSAmax (p = 0.012) and IEP (p = 0.020) showed significant statistical differences. The multivariate regression analysis suggested that CSAmax (in CEM or MR) and %RSCC were independent predictors of DCISM (all p < 0.05). The area under the curve (AUC) of CSAmax (CEM), %RSCC (CEM), Logit(P) (CEM), and CSAmax (MR) were 0.764, 0.795, 0.842, and 0.739, respectively. There were no significant differences in DeLong's test for these values (all p > 0.10). DCISM was significantly associated with high nuclear grade, comedo type, high axillary lymph node (ALN) metastasis, and high Ki-67 positivity compared to DCIS (all p < 0.05).
CONCLUSION: The tumor size (CSAmax), enhancement index (%RS), and internal enhancement pattern (IEP) were highly indicative of DCISM. DCISM tends to express more aggressive pathological features, such as high nuclear grade, comedo-type necrosis, ALN metastasis, and Ki-67 overexpression. As with MRI, CEM has the capability to help predict when DCISM is accompanying DCIS.
引用
- Hua B, Yang G, An Y, et al. Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ. Acad Radiol. 2024. PMID: 38734581. doi:10.1016/j.acra.2024.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。